img

Global Antivenene Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antivenene Market Insights, Forecast to 2034

Antivenene, also known as antivenom, is a medical treatment used to counteract the effects of venom from poisonous animals, such as snakes, spiders, scorpions, and insects. It is produced by immunizing animals, such as horses or sheep, with controlled amounts of venom. The antibodies generated in these animals' blood are then collected and purified to create antivenene. When administered to humans bitten or stung by venomous creatures, antivenene neutralizes the toxins and prevents severe or life-threatening reactions.
Global Antivenene market is expected to reach to US$ 1012 million in 2024, with a positive growth of %, compared with US$ 959 million in 2022. Backed with the increasing demand from downstream industries, Antivenene industry is evaluated to reach US$ 1299.8 million in 2029. The CAGR will be 4.3% during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Antivenene market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Antivenene market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Segment by Type
Polyvalent Antivenene
Monovalent Antivenene

Segment by Application


Non-profit Institutions
Hospitals and Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Antivenene plant distribution, commercial date of Antivenene, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Antivenene introduction, etc. Antivenene Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Antivenene
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Antivenene Product Introduction
1.2 Market by Type
1.2.1 Global Antivenene Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Polyvalent Antivenene
1.2.3 Monovalent Antivenene
1.3 Market by Application
1.3.1 Global Antivenene Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antivenene Sales Estimates and Forecasts 2018-2029
2.2 Global Antivenene Revenue by Region
2.2.1 Global Antivenene Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antivenene Revenue by Region (2018-2024)
2.2.3 Global Antivenene Revenue by Region (2024-2029)
2.2.4 Global Antivenene Revenue Market Share by Region (2018-2029)
2.3 Global Antivenene Sales Estimates and Forecasts 2018-2029
2.4 Global Antivenene Sales by Region
2.4.1 Global Antivenene Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antivenene Sales by Region (2018-2024)
2.4.3 Global Antivenene Sales by Region (2024-2029)
2.4.4 Global Antivenene Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antivenene Sales by Manufacturers
3.1.1 Global Antivenene Sales by Manufacturers (2018-2024)
3.1.2 Global Antivenene Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antivenene in 2022
3.2 Global Antivenene Revenue by Manufacturers
3.2.1 Global Antivenene Revenue by Manufacturers (2018-2024)
3.2.2 Global Antivenene Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antivenene Revenue in 2022
3.3 Global Key Players of Antivenene, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Antivenene Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antivenene Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antivenene, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antivenene, Product Offered and Application
3.8 Global Key Manufacturers of Antivenene, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antivenene Sales by Type
4.1.1 Global Antivenene Historical Sales by Type (2018-2024)
4.1.2 Global Antivenene Forecasted Sales by Type (2024-2029)
4.1.3 Global Antivenene Sales Market Share by Type (2018-2029)
4.2 Global Antivenene Revenue by Type
4.2.1 Global Antivenene Historical Revenue by Type (2018-2024)
4.2.2 Global Antivenene Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antivenene Revenue Market Share by Type (2018-2029)
4.3 Global Antivenene Price by Type
4.3.1 Global Antivenene Price by Type (2018-2024)
4.3.2 Global Antivenene Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antivenene Sales by Application
5.1.1 Global Antivenene Historical Sales by Application (2018-2024)
5.1.2 Global Antivenene Forecasted Sales by Application (2024-2029)
5.1.3 Global Antivenene Sales Market Share by Application (2018-2029)
5.2 Global Antivenene Revenue by Application
5.2.1 Global Antivenene Historical Revenue by Application (2018-2024)
5.2.2 Global Antivenene Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antivenene Revenue Market Share by Application (2018-2029)
5.3 Global Antivenene Price by Application
5.3.1 Global Antivenene Price by Application (2018-2024)
5.3.2 Global Antivenene Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antivenene Market Size by Type
6.1.1 US & Canada Antivenene Sales by Type (2018-2029)
6.1.2 US & Canada Antivenene Revenue by Type (2018-2029)
6.2 US & Canada Antivenene Market Size by Application
6.2.1 US & Canada Antivenene Sales by Application (2018-2029)
6.2.2 US & Canada Antivenene Revenue by Application (2018-2029)
6.3 US & Canada Antivenene Market Size by Country
6.3.1 US & Canada Antivenene Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antivenene Sales by Country (2018-2029)
6.3.3 US & Canada Antivenene Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antivenene Market Size by Type
7.1.1 Europe Antivenene Sales by Type (2018-2029)
7.1.2 Europe Antivenene Revenue by Type (2018-2029)
7.2 Europe Antivenene Market Size by Application
7.2.1 Europe Antivenene Sales by Application (2018-2029)
7.2.2 Europe Antivenene Revenue by Application (2018-2029)
7.3 Europe Antivenene Market Size by Country
7.3.1 Europe Antivenene Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antivenene Sales by Country (2018-2029)
7.3.3 Europe Antivenene Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antivenene Market Size
8.1.1 China Antivenene Sales (2018-2029)
8.1.2 China Antivenene Revenue (2018-2029)
8.2 China Antivenene Market Size by Application
8.2.1 China Antivenene Sales by Application (2018-2029)
8.2.2 China Antivenene Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antivenene Market Size by Type
9.1.1 Asia Antivenene Sales by Type (2018-2029)
9.1.2 Asia Antivenene Revenue by Type (2018-2029)
9.2 Asia Antivenene Market Size by Application
9.2.1 Asia Antivenene Sales by Application (2018-2029)
9.2.2 Asia Antivenene Revenue by Application (2018-2029)
9.3 Asia Antivenene Sales by Region
9.3.1 Asia Antivenene Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antivenene Revenue by Region (2018-2029)
9.3.3 Asia Antivenene Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antivenene Market Size by Type
10.1.1 Middle East, Africa and Latin America Antivenene Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antivenene Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antivenene Market Size by Application
10.2.1 Middle East, Africa and Latin America Antivenene Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antivenene Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antivenene Sales by Country
10.3.1 Middle East, Africa and Latin America Antivenene Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antivenene Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antivenene Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL
11.1.1 CSL Company Information
11.1.2 CSL Overview
11.1.3 CSL Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CSL Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 BTG
11.3.1 BTG Company Information
11.3.2 BTG Overview
11.3.3 BTG Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 BTG Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BTG Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Company Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Haffkine Bio-Pharmaceutical Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Rare Disease Therapeutics
11.6.1 Rare Disease Therapeutics Company Information
11.6.2 Rare Disease Therapeutics Overview
11.6.3 Rare Disease Therapeutics Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Rare Disease Therapeutics Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Rare Disease Therapeutics Recent Developments
11.7 Flynn Pharma
11.7.1 Flynn Pharma Company Information
11.7.2 Flynn Pharma Overview
11.7.3 Flynn Pharma Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Flynn Pharma Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Flynn Pharma Recent Developments
11.8 Vins Bioproducts
11.8.1 Vins Bioproducts Company Information
11.8.2 Vins Bioproducts Overview
11.8.3 Vins Bioproducts Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Vins Bioproducts Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Vins Bioproducts Recent Developments
11.9 Bharat Serums and Vaccines
11.9.1 Bharat Serums and Vaccines Company Information
11.9.2 Bharat Serums and Vaccines Overview
11.9.3 Bharat Serums and Vaccines Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Bharat Serums and Vaccines Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bharat Serums and Vaccines Recent Developments
11.10 Serum Biotech
11.10.1 Serum Biotech Company Information
11.10.2 Serum Biotech Overview
11.10.3 Serum Biotech Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Serum Biotech Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Serum Biotech Recent Developments
11.11 MicroPharm
11.11.1 MicroPharm Company Information
11.11.2 MicroPharm Overview
11.11.3 MicroPharm Antivenene Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 MicroPharm Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 MicroPharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antivenene Industry Chain Analysis
12.2 Antivenene Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antivenene Production Mode & Process
12.4 Antivenene Sales and Marketing
12.4.1 Antivenene Sales Channels
12.4.2 Antivenene Distributors
12.5 Antivenene Customers
13 Market Dynamics
13.1 Antivenene Industry Trends
13.2 Antivenene Market Drivers
13.3 Antivenene Market Challenges
13.4 Antivenene Market Restraints
14 Key Findings in The Global Antivenene Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antivenene Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Polyvalent Antivenene
Table 3. Major Manufacturers of Monovalent Antivenene
Table 4. Global Antivenene Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Antivenene Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Antivenene Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Antivenene Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Antivenene Revenue Market Share by Region (2018-2024)
Table 9. Global Antivenene Revenue Market Share by Region (2024-2029)
Table 10. Global Antivenene Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Antivenene Sales by Region (2018-2024) & (K Units)
Table 12. Global Antivenene Sales by Region (2024-2029) & (K Units)
Table 13. Global Antivenene Sales Market Share by Region (2018-2024)
Table 14. Global Antivenene Sales Market Share by Region (2024-2029)
Table 15. Global Antivenene Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Antivenene Sales Share by Manufacturers (2018-2024)
Table 17. Global Antivenene Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Antivenene Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Antivenene, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Antivenene Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Antivenene Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Antivenene by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivenene as of 2022)
Table 23. Global Key Manufacturers of Antivenene, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Antivenene, Product Offered and Application
Table 25. Global Key Manufacturers of Antivenene, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antivenene Sales by Type (2018-2024) & (K Units)
Table 28. Global Antivenene Sales by Type (2024-2029) & (K Units)
Table 29. Global Antivenene Sales Share by Type (2018-2024)
Table 30. Global Antivenene Sales Share by Type (2024-2029)
Table 31. Global Antivenene Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Antivenene Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Antivenene Revenue Share by Type (2018-2024)
Table 34. Global Antivenene Revenue Share by Type (2024-2029)
Table 35. Antivenene Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Antivenene Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Antivenene Sales by Application (2018-2024) & (K Units)
Table 38. Global Antivenene Sales by Application (2024-2029) & (K Units)
Table 39. Global Antivenene Sales Share by Application (2018-2024)
Table 40. Global Antivenene Sales Share by Application (2024-2029)
Table 41. Global Antivenene Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Antivenene Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Antivenene Revenue Share by Application (2018-2024)
Table 44. Global Antivenene Revenue Share by Application (2024-2029)
Table 45. Antivenene Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Antivenene Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Antivenene Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Antivenene Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Antivenene Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Antivenene Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Antivenene Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Antivenene Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Antivenene Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Antivenene Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Antivenene Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Antivenene Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Antivenene Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Antivenene Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Antivenene Sales by Country (2024-2029) & (K Units)
Table 60. Europe Antivenene Sales by Type (2018-2024) & (K Units)
Table 61. Europe Antivenene Sales by Type (2024-2029) & (K Units)
Table 62. Europe Antivenene Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Antivenene Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Antivenene Sales by Application (2018-2024) & (K Units)
Table 65. Europe Antivenene Sales by Application (2024-2029) & (K Units)
Table 66. Europe Antivenene Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Antivenene Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Antivenene Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Antivenene Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Antivenene Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Antivenene Sales by Country (2018-2024) & (K Units)
Table 72. Europe Antivenene Sales by Country (2024-2029) & (K Units)
Table 73. China Antivenene Sales by Type (2018-2024) & (K Units)
Table 74. China Antivenene Sales by Type (2024-2029) & (K Units)
Table 75. China Antivenene Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Antivenene Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Antivenene Sales by Application (2018-2024) & (K Units)
Table 78. China Antivenene Sales by Application (2024-2029) & (K Units)
Table 79. China Antivenene Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Antivenene Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Antivenene Sales by Type (2018-2024) & (K Units)
Table 82. Asia Antivenene Sales by Type (2024-2029) & (K Units)
Table 83. Asia Antivenene Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Antivenene Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Antivenene Sales by Application (2018-2024) & (K Units)
Table 86. Asia Antivenene Sales by Application (2024-2029) & (K Units)
Table 87. Asia Antivenene Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Antivenene Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Antivenene Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Antivenene Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Antivenene Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Antivenene Sales by Region (2018-2024) & (K Units)
Table 93. Asia Antivenene Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Antivenene Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Antivenene Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Antivenene Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Antivenene Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Antivenene Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Antivenene Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Antivenene Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Antivenene Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Antivenene Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Antivenene Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Antivenene Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Antivenene Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Antivenene Sales by Country (2024-2029) & (K Units)
Table 107. CSL Company Information
Table 108. CSL Description and Major Businesses
Table 109. CSL Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. CSL Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Recent Developments
Table 112. Merck Company Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. BTG Company Information
Table 118. BTG Description and Major Businesses
Table 119. BTG Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. BTG Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. BTG Recent Developments
Table 122. Pfizer Company Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Haffkine Bio-Pharmaceutical Company Information
Table 128. Haffkine Bio-Pharmaceutical Description and Major Businesses
Table 129. Haffkine Bio-Pharmaceutical Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Haffkine Bio-Pharmaceutical Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Haffkine Bio-Pharmaceutical Recent Developments
Table 132. Rare Disease Therapeutics Company Information
Table 133. Rare Disease Therapeutics Description and Major Businesses
Table 134. Rare Disease Therapeutics Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Rare Disease Therapeutics Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Rare Disease Therapeutics Recent Developments
Table 137. Flynn Pharma Company Information
Table 138. Flynn Pharma Description and Major Businesses
Table 139. Flynn Pharma Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Flynn Pharma Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Flynn Pharma Recent Developments
Table 142. Vins Bioproducts Company Information
Table 143. Vins Bioproducts Description and Major Businesses
Table 144. Vins Bioproducts Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Vins Bioproducts Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Vins Bioproducts Recent Developments
Table 147. Bharat Serums and Vaccines Company Information
Table 148. Bharat Serums and Vaccines Description and Major Businesses
Table 149. Bharat Serums and Vaccines Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Bharat Serums and Vaccines Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Bharat Serums and Vaccines Recent Developments
Table 152. Serum Biotech Company Information
Table 153. Serum Biotech Description and Major Businesses
Table 154. Serum Biotech Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Serum Biotech Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Serum Biotech Recent Developments
Table 157. MicroPharm Company Information
Table 158. MicroPharm Description and Major Businesses
Table 159. MicroPharm Antivenene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. MicroPharm Antivenene Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. MicroPharm Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Antivenene Distributors List
Table 165. Antivenene Customers List
Table 166. Antivenene Market Trends
Table 167. Antivenene Market Drivers
Table 168. Antivenene Market Challenges
Table 169. Antivenene Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenene Product Picture
Figure 2. Global Antivenene Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antivenene Market Share by Type in 2022 & 2029
Figure 4. Polyvalent Antivenene Product Picture
Figure 5. Monovalent Antivenene Product Picture
Figure 6. Global Antivenene Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Antivenene Market Share by Application in 2022 & 2029
Figure 8. Non-profit Institutions
Figure 9. Hospitals and Clinic
Figure 10. Antivenene Report Years Considered
Figure 11. Global Antivenene Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Antivenene Revenue 2018-2029 (US$ Million)
Figure 13. Global Antivenene Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Antivenene Revenue Market Share by Region (2018-2029)
Figure 15. Global Antivenene Sales 2018-2029 ((K Units)
Figure 16. Global Antivenene Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Antivenene Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Antivenene Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Antivenene Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Antivenene Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Antivenene Sales YoY (2018-2029) & (K Units)
Figure 22. China Antivenene Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Antivenene Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Antivenene Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Antivenene Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Antivenene Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Antivenene Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Antivenene in the World: Market Share by Antivenene Revenue in 2022
Figure 29. Global Antivenene Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Antivenene Sales Market Share by Type (2018-2029)
Figure 31. Global Antivenene Revenue Market Share by Type (2018-2029)
Figure 32. Global Antivenene Sales Market Share by Application (2018-2029)
Figure 33. Global Antivenene Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Antivenene Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Antivenene Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Antivenene Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Antivenene Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Antivenene Revenue Share by Country (2018-2029)
Figure 39. US & Canada Antivenene Sales Share by Country (2018-2029)
Figure 40. U.S. Antivenene Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Antivenene Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Antivenene Sales Market Share by Type (2018-2029)
Figure 43. Europe Antivenene Revenue Market Share by Type (2018-2029)
Figure 44. Europe Antivenene Sales Market Share by Application (2018-2029)
Figure 45. Europe Antivenene Revenue Market Share by Application (2018-2029)
Figure 46. Europe Antivenene Revenue Share by Country (2018-2029)
Figure 47. Europe Antivenene Sales Share by Country (2018-2029)
Figure 48. Germany Antivenene Revenue (2018-2029) & (US$ Million)
Figure 49. France Antivenene Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Antivenene Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Antivenene Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Antivenene Revenue (2018-2029) & (US$ Million)
Figure 53. China Antivenene Sales Market Share by Type (2018-2029)
Figure 54. China Antivenene Revenue Market Share by Type (2018-2029)
Figure 55. China Antivenene Sales Market Share by Application (2018-2029)
Figure 56. China Antivenene Revenue Market Share by Application (2018-2029)
Figure 57. Asia Antivenene Sales Market Share by Type (2018-2029)
Figure 58. Asia Antivenene Revenue Market Share by Type (2018-2029)
Figure 59. Asia Antivenene Sales Market Share by Application (2018-2029)
Figure 60. Asia Antivenene Revenue Market Share by Application (2018-2029)
Figure 61. Asia Antivenene Revenue Share by Region (2018-2029)
Figure 62. Asia Antivenene Sales Share by Region (2018-2029)
Figure 63. Japan Antivenene Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Antivenene Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Antivenene Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Antivenene Revenue (2018-2029) & (US$ Million)
Figure 67. India Antivenene Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Antivenene Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Antivenene Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Antivenene Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Antivenene Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Antivenene Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Antivenene Sales Share by Country (2018-2029)
Figure 74. Brazil Antivenene Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Antivenene Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Antivenene Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Antivenene Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Antivenene Revenue (2018-2029) & (US$ Million)
Figure 79. Antivenene Value Chain
Figure 80. Antivenene Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries